Naijun Chen

2.0k citations

46 papers · 1.5k indexed · 1 hit paper · h-index 20

Impact in

Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
Hematology top 5%
- Autoimmune and Inflammatory Disorders Research

Papers in ⓘ

Rheumatology 13
- Rheumatoid Arthritis Research and Therapies 11
- Spondyloarthritis Studies and Treatments 5
Hematology 9
- Autoimmune and Inflammatory Disorders Research 9

Co-authors: Jingdong Chao (19 shared papers)Susan Bressman (1 shared paper)Inga Peter (1 shared paper)Marla Dubinsky (1 shared paper)Parvez Mulani (17 shared papers)Andrew Park (1 shared paper)Anthony Wang (1 shared paper)Mary Cifaldi (5 shared papers)
Journals: Gastroenterology (10 papers)The American Journal of Gastroenterology (5 papers)Medicine (2 papers)Lara D. Veeken (2 papers)Journal of Crohn s and Colitis (2 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Naijun Chen

43 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

Anti–Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease 2018 · 286 citations

Peers

Countries citing papers authored by Naijun Chen

Since Specialization

Citations

This map shows the geographic impact of Naijun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naijun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naijun Chen more than expected).

Fields of papers citing papers by Naijun Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naijun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naijun Chen. The network helps show where Naijun Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Naijun Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Naijun Chen Line = papers co-authored together Naijun Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Anti–Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease JAMA Neurology ·Inga Peter, Marla Dubinsky, Susan Bressman, Andrew Park, Chuang-Hui Lu, Naijun Chen, Anthony Wang Hit paper breakdown →	2018	286
2	Adalimumab Induces Deep Remission in Patients With Crohn's Disease Clinical Gastroenterology and Hepatology ·Jean‐Frédéric Colombel, Paul Rutgeerts, William J. Sandborn, Mei Yang, Anne Camez, Paul F. Pollack, Roopal Thakkar, Anne Robinson, Naijun Chen, Parvez Mulani, Jingdong Chao	2013	191
3	¹³C NMR Study of Halogen Bonding of Haloarenes: Measurements of Solvent Effects and Theoretical Analysis Journal of the American Chemical Society ·Rainer Glaser, Naijun Chen, Hong Wu, Nathan Knotts, Martin Kaupp	2004	117
4	Adalimumab Therapy Is Associated With Reduced Risk of Hospitalization in Patients With Ulcerative Colitis Gastroenterology ·Brian G. Feagan, William J. Sandborn, Andreas Lazar, Roopal Thakkar, Bidan Huang, Nattanan Reilly, Naijun Chen, Mei Yang, Martha Skup, Parvez Mulani, Jingdong Chao	2013	76
5	Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS). PubMed ·Dennis A. Revicki, Michelle P. Luo, P Wordsworth, Robert Wong, Naijun Chen, John C. Davis	2008	62
6	Health-related Quality of Life Outcomes of Adalimumab for Patients with Early Rheumatoid Arthritis: Results from a Randomized Multicenter Study The Journal of Rheumatology ·Vibeke Strand, Anne M. Rentz, Mary Cifaldi, Naijun Chen, Sanjoy Roy, Dennis A. Revicki	2011	58
7	Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial SHILAP Revista de lepidopterología ·Remo Panaccione, Edward V. Loftus, David G. Binion, Kevin J. McHugh, Shamsul Alam, Naijun Chen, B. Guérette, Parvez Mulani, Jingdong Chao	2011	58
8	Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate Annals of the Rheumatic Diseases ·Josef S Smolen, Désirée van der Heijde, Edward Keystone, Ronald van Vollenhoven, Mary B. Goldring, B. Guérette, Mary Cifaldi, Naijun Chen, Shufang Liu, Robert Landewé	2012	55
9	Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials JAMA Ophthalmology ·John D. Sheppard, Avani Joshi, Keith A. Betts, Stacie Hudgens, Samir Tari, Naijun Chen, Martha Skup, Andrew D. Dick	2017	54
10	Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: Work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study Arthritis Care & Research ·Ronald van Vollenhoven, Mary Cifaldi, Saurabh Ray, Naijun Chen, Michael H. Weisman	2010	53
11	Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA. PubMed ·Miriam Kimel, Mary Cifaldi, Naijun Chen, Dennis A. Revicki	2008	52
12	ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis Lara D. Veeken ·Désirée van der Heijde, Avani Joshi, Aileen L. Pangan, Naijun Chen, Keith A. Betts, Manish Mittal, Yanjun Bao	2015	50
13	Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial Journal of Crohn s and Colitis ·Édouard Louis, Robert Löfberg, Walter Reinisch, Anne Camez, Mei Yang, Paul F. Pollack, Naijun Chen, Jingdong Chao, Parvez Mulani	2012	46
14	Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA Journal of Crohn s and Colitis ·Simon Travis, Brian G. Feagan, Laurent Peyrin‐Biroulet, Remo Panaccione, Silvio Danese, Andreas Lazar, Anne Robinson, Joel Petersson, Brandee Pappalardo, Mareike Bereswill, Naijun Chen, Song Wang, Martha Skup, Roopal Thakkar, Jingdong Chao	2017	36
15	Thresholds of patient‐reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristics Arthritis Care & Research ·Walter P. Maksymowych, Katherine Gooch, Maxime Dougados, Robert Wong, Naijun Chen, H. Küpper, Désirée van der Heijde	2010	33
16	Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: Data from a randomized controlled trial Arthritis Care & Research ·Maxime Dougados, Michelle P. Luo, Walter P. Maksymowych, Joseph J. Chmiel, Naijun Chen, Robert Wong, John C. Davis, Désirée van der Heijde, (unknown)	2008	33
17	P‐119: Low Cost Perovskite Quantum Dots Film Based Wide Color Gamut Backlight Unit for LCD TVs SID Symposium Digest of Technical Papers ·Naijun Chen, Zelong Bai, Zengmin Wang, Honglei Ji, Ruikuo Liu, Chaowei Cao, Hui Wang, Feng Jiang, Haizheng Zhong	2018	32
18	Evaluation of Adherence and Persistence Differences Between Adalimumab Citrate-Free and Citrate Formulations for Patients with Immune-Mediated Diseases in the United States Rheumatology and Therapy ·Martin Bergman, Pankaj Patel, Naijun Chen, Yonghua Jing, Christopher D. Saffore	2020	28
19	Adalimumab Improves Sleep and Sleep Quality in Patients with Active Ankylosing Spondylitis The Journal of Rheumatology ·Martín Rudwaleit, Katherine Gooch, Beat A. Michel, Manfred Herold, Å Thörner, Robert Wong, Martina Kron, Naijun Chen, H. Küpper	2010	28
20	Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study Rheumatology and Therapy ·Filip Van den Bosch, Andrew J.K. Östör, Siegfried Wassenberg, Naijun Chen, Chen Wang, Vishvas Garg, Jasmina Kalabic	2017	24

About Naijun Chen

Naijun Chen is a scholar working on Rheumatology, Hematology, Genetics, Epidemiology and Speech and Hearing, having authored 46 papers that have together received 1.5k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (21 papers), Microscopic Colitis (20 papers), Rheumatoid Arthritis Research and Therapies (11 papers), Autoimmune and Inflammatory Disorders Research (9 papers), Eosinophilic Esophagitis (5 papers), Spondyloarthritis Studies and Treatments (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Adolescent and Pediatric Healthcare (3 papers). The work is most often cited by research in Rheumatology (442 citations), Hematology (226 citations), Genetics (480 citations), Neurology (127 citations) and Gastroenterology (70 citations). Naijun Chen has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Jingdong Chao, Susan Bressman, Inga Peter, Marla Dubinsky, Parvez Mulani, Andrew Park, Anthony Wang, Mary Cifaldi, Dennis A. Revicki and Roopal Thakkar. Their work appears in journals such as Gastroenterology, The American Journal of Gastroenterology, Medicine, Lara D. Veeken and Journal of Crohn s and Colitis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact